Should You Buy Dechra Pharmaceuticals plc, Enquest Plc & Cairn Energy PLC Today?

Royston Wild runs the rule over headline makers Dechra Pharmaceuticals plc (LON: DPH), Enquest Plc (LON: ENQ) and Cairn Energy PLC (LON: CNE).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m looking at three stocks making the news in start-of-week business.

Drugs delight marches on

Pet medicines mammoth Dechra Pharmaceuticals (LSE: DPH) cheered the market with terrific half-year numbers in Monday business, propelling the stock 8% higher from the end of last week.

Dechra advised that group revenues surged 9.7% between July and December, to £110.7m, while underlying operating profits galloped 24.2% higher to £26.3m.

The pharma play’s North American division was again the standout performer, where new product launches and an increase in its sales force helped drive demand 59.1% higher from the same period last year. Meanwhile, last October’s purchase of poultry vaccines manufacturer Genera is also paying off handsomely, the unit contributing £3.4m in revenues during the half.

The City expects Dechra to enjoy a 3% earnings rise in the year to June 2016, leaving the business dealing on a conventionally-high P/E rating of 23.3 times.

Still, I believe in the firm’s strong position in the fast-growing animal medicines market, helped in no small part by the strength of its product pipeline. The company received regulatory approval for its Zycortal canine and Osphos horse treatments during July-December and I reckon Dechra is still an attractive growth pick at current prices.

Oilies on the acquisition trail

Oil explorers Cairn Energy (LSE: CNE) and Enquest (LSE: ENQ) both saw their share values head higher in Monday business following news of acquisition activity in the North Sea.

Enquest announced it had purchased an extra 10.5% holding in the Kraken development from First Oil, taking its total stake in the asset to 70.5%. As part of the deal Enquest will waive its right to claw back $7m worth of cash calls paid on behalf of First Oil.

Meanwhile, Cairn Energy has increased its stake in Kraken to 29.5% after its Nautical Petroleum subsidiary purchased an extra 4.5% worth of shares from First Oil.

The Kraken development is undoubtedly a terrific offshore asset, and its estimated 25-year life is due to kick off with maiden production during the first half of 2017. But I believe the fragile state of the broader oil market still makes Enquest and Cairn Energy unattractive picks at the present time.

Sure, talks between certain OPEC nations and Russia concerning future output are a step in the right direction. But the political and commercial obstacles in place remain colossal, and I certainly wouldn’t place a wager on a deal being hammered out any time soon.

And with global demand indicators steadily disappointing, I believe the risks continue to outweigh the potential rewards at Cairn Energy and Enquest as subdued revenues and huge capex costs endure. The City expects both firms to experience further losses in 2016, and I don’t foresee either firm flipping into the black any time soon.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

The flag of the United States of America flying in front of the Capitol building
Investing Articles

2 UK shares that could rise if Trump wins the Presidential election

These UK shares are among the FTSE 100's most popular stocks. And they could rise in value if Donald Trump…

Read more »

Closeup ruffled American flag representing US stocks and shares
Investing Articles

2 UK stocks that could rise if Harris wins the Presidential election

Royston Wild believes these UK stocks could receive a bump if Kalama Harris wins the Presidency, giving their share prices…

Read more »

Investing Articles

After a 96% plunge, is buying more Aston Martin shares throwing good money after bad?

Just two weeks after buying Aston Martin shares Harvey Jones found himself nursing a painful loss. Yet after recent news…

Read more »

Investing Articles

After crashing 45% in October, should I buy this FTSE 250 share for my Stocks and Shares ISA?

Roland Head explains why he’s tempted to add this risky FTSE 250 turnaround share to his Stocks and Shares ISA…

Read more »

Investing Articles

Could I use a stock market crash to turn £20k into half a mil in just over a decade?

A stock market crash might sound terrifying to some but it can also present a once-in-a-lifetime opportunity to accumulate generational…

Read more »

Investing Articles

Recently released: October’s small-cap stock recommendation [PREMIUM PICKS]

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Read more »

Investing Articles

Here’s how a Stocks and Shares ISA and Lifetime ISA could supercharge my wealth!

Individual Savings Accounts (ISAs) can help UK share investors take their earnings to the next level. And their importance is…

Read more »

A person holding onto a fan of twenty pound notes
Investing Articles

A high-yield dividend ETF and an investment trust to consider this November!

Investors wanting to boost their passive income could benefit from investigating these high-yield funds and trusts, says Royston Wild.

Read more »